Table 1.
References | Source | Cell harvest | Cell treatment | MSC characterization |
---|---|---|---|---|
Khatab et al. (2018) | Human | Heparinised femoral shaft bone marrow aspirate | Cultured in minimal essential medium alpha (α MEM), Fetal Calf Serum (FCS) and Invitrogen to third passage | Trilineage differentiation, Flow cytometry: CD73, CD90, CD105, CD166 +ve |
Mao et al. (2018) | Human | Bone marrow aspirate from iliac crest | Cultured in astandard Mesenchymal Stem Cell (MSC) media and changed to chondrogenic media from third passage onwards. miR-92a-3p overexpressed in one group | Trilineage differentiation, Flow cytometry: CD11b, CD19, CD34, CD45, CD73, CD90, CD105, and HLA-DR –ve |
Tao et al. (2017) | Human | Synovial membrane tissue | Cultured in standard MSC media to fifth passage. miR-140-5p overexpressed in one group | Trilineage differentiation, Flow cytometry: CD44, CD73, CD90, CD105, CD151 +ve |
Wang et al. (2017) | Human | Embryonic stem cell-derived MSCs (obtained from third party) | Cultured in standard MSC media and cells between fourth and seventh passage were utilized | Trilineage differentiation, Flow cytometry: CD73, CD90, CD105 +ve |
Wu et al. (2019) | Human | Infrapatellar fat pad obtained following total knee arthroplasty | Cultured in standard MSC media to confluence and used at first passage | Flow Cytometry: CD44, CD73, CD90 +ve. CD34, CD11b, CD19, CD45, HLA-DR present at low levels |
Zhang et al. (2016) | Human | Cleavage and blastocyst- stage embryonic stem cells from in vitro fertilization | Cultured in standard MSC media. Further details not stated | Trilineage differentiation, Flow cytometry: CD105, CD24 +ve |
Zhang et al. (2018) | Human | Immortalized E1-Myc 16.3 embryonic stem cell-derived MSC | Cultured in standard MSC media and passaged at 80% confluence until use. Grown in defined media for 3 days prior to exosome extraction | Trilineage differentiation, Flow cytometry: CD29, CD44, CD90, CD105 +ve, CD34, CD45, HLA-DR –ve |
Zhang et al. (2019) | Human | Immortalized E1-Myc 16.3 embryonic stem cell-derived MSC | Cultured in standard MSC media and passaged at 80% confluence until use. Grown in defined media for 3 days prior to exosome extraction | Trilineage differentiation, Flow cytometry: CD29, CD44, CD90, CD105 +ve, CD34, CD45, HLA-DR –ve |
Zhu Y. et al. (2017) | Human | Induced pluripotent stem cell-derived MSC (iMSC) induced from human umbilical cord iPS Synovial MSC (sMSC) from humans undergoing Anterior crucial efforts ligament (ACL) reconstruction |
iMSC: iPS cultured for 5 days in mTESR1 (Stemcell) and then cultured in standard MSC media for 2 weeks. The cells were then passaged every 5–7 days until a fibroblastic morphology was adopted sMSC: cultured in standard MSC media, with media changed every 4 days |
Trilineage differentiation Flow cytometry: iMSC: CD29, CD44, CD73, CD90 +ve. CD34, CD45, HLA-DR –ve sMSC: CD44, CD73, CD90, CD166 +ve. CD34, CD4, HLA-DR –ve |
Jin et al. (2020) | Human | MSCs derived from bone marrow aspirate from the ilium of healthy subjects | Cultured to third to fifth passage with media changed every 48 h | Trilineage differentiation. Flow cytometry: CD29, CD44, CD71 +ve. CD34, CD45, and HLA-DR -ve |
refers to individual culture condition protocol without addition of stimulating factors.